StockData
Decoy Therapeutics Inc. logo

Decoy Therapeutics Inc. (DCOY) stock

DCOYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.95+0.05 (+5.37%)

Close on Nov 17, 2026Market cap $622.03KP/E –Yield –

Decoy Therapeutics r&d expenses

Research and development expenses are spending on new products and technology.

Decoy Therapeutics's R&D Expenses for the twelve months ending Jun 30, 2026 was $2.23M, up 342.1% year over year. For fiscal 2025 it was $368.17K, down 52.2% from the year before. Over ten years it grew -29.8% a year on average. The highest annual figure on record is $20.38M in fiscal 2016.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$368.17K-52.2%
FY2024Dec 31, 2024$770.03K-89.3%
FY2023Dec 31, 2023$7.17M-54.7%
FY2022Dec 31, 2022$15.84M+85.3%
FY2021Dec 31, 2021$8.55M+23.6%
FY2020Dec 31, 2020$6.91M+72.0%
FY2019Dec 31, 2019$4.02M+212.1%
FY2018Dec 31, 2018$1.29M-92.4%
FY2017Dec 31, 2017$16.99M-16.6%
FY2016Dec 31, 2016$20.38M+59.8%
FY2015Dec 31, 2015$12.75M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.30M+1020.7%
Q1 FY2026Mar 31, 2026$749.81K+892.7%
Q4 FY2025Dec 31, 2025$114.43K-34.7%
Q3 FY2025Sep 30, 2025$61.83K-54.9%
Q2 FY2025Jun 30, 2025$116.38K-45.7%
Q1 FY2025Mar 31, 2025$75.53K-68.9%
Q4 FY2024Dec 31, 2024$175.34K+192.5%
Q3 FY2024Sep 30, 2024$137.23K-86.8%
Q2 FY2024Jun 30, 2024$214.45K-90.9%
Q1 FY2024Mar 31, 2024$243.00K-93.5%
Q4 FY2023Dec 31, 2023$59.95K-98.7%
Q3 FY2023Sep 30, 2023$1.04M-72.7%
Q2 FY2023Jun 30, 2023$2.35M-19.5%
Q1 FY2023Mar 31, 2023$3.73M-16.1%
Q4 FY2022Dec 31, 2022$4.69M+73.8%
Q3 FY2022Sep 30, 2022$3.79M+88.0%
Q2 FY2022Jun 30, 2022$2.92M+39.4%
Q1 FY2022Mar 31, 2022$4.44M+155.0%
Q4 FY2021Dec 31, 2021$2.70M+33.2%
Q3 FY2021Sep 30, 2021$2.02M+11.8%
Q2 FY2021Jun 30, 2021$2.10M+45.2%
Q1 FY2021Mar 31, 2021$1.74M+5.9%
Q4 FY2020Dec 31, 2020$2.02M+51.2%
Q3 FY2020Sep 30, 2020$1.80M+58.1%
Q2 FY2020Jun 30, 2020$1.44M+71.8%
Q1 FY2020Mar 31, 2020$1.64M+134.8%
Q4 FY2019Dec 31, 2019$1.34M+612.6%
Q3 FY2019Sep 30, 2019$1.14M+222.6%
Q2 FY2019Jun 30, 2019$840.14K-86.4%
Q1 FY2019Mar 31, 2019$699.93K-85.0%
Q4 FY2018Dec 31, 2018$187.76K-95.6%
Q3 FY2018Sep 30, 2018$353.61K-92.5%
Q2 FY2018Jun 30, 2018$6.17M+51.5%
Q1 FY2018Mar 31, 2018$4.68M+19.5%
Q4 FY2017Dec 31, 2017$4.26M+0.7%
Q3 FY2017Sep 30, 2017$4.74M-16.3%
Q2 FY2017Jun 30, 2017$4.08M–
Q1 FY2017Mar 31, 2017$3.91M–
Q4 FY2016Dec 31, 2016$4.23M–
Q3 FY2016Sep 30, 2016$5.67M–

More Decoy Therapeutics figures

See a number that looks wrong?